RxDoctor Payments Data

Emma Stossel, PA

Physician Assistant · Jacksonville, NCNPI 1083486138

Payments from drug & device makers

$497in general payments, 2019–2025

Across 26 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$218
  • Shield Therapeutics Inc$49
  • Novo Nordisk$42
  • AbbVie$35
  • Amgen$33
  • AstraZeneca$29
  • plus $92 from 5 others

What the payments were for

  • Food & beverage$497100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$497 in reported general payments places this provider in the 55th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$10,988
Medicare patients
108
Services billed
366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$22,178
TrulicityDulaglutide14$13,354
OzempicSemaglutide11$12,044
Albuterol Sulfate HfaAlbuterol Sulfate44$976
Betamethasone Dipropionate11$788
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav56$573
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$445
Montelukast Sodium27$435
Fluticasone Propionate25$394
Ondansetron OdtOndansetron22$377
Gabapentin26$367
Trazodone Hcl43$365
Duloxetine Hcl18$328
Atorvastatin Calcium18$320
Fluoxetine Hcl11$320

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$218$22,17827 claims
Lilly USA, LLCTrulicity$14$13,35414 claims
Novo NordiskOzempic$42$12,04411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Jacksonville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →